🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: \- Multiple myeloma (MM) is a type of malignant blood cancer. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-03-27
Trial ID
NCT01571726
Treatments Being Tested
Positron emission tomography (PET) is a non-invasive imaging tool for monit...
Status
Terminated
Location
Asan Medical Center
Start Date
2013-09
Trial ID
NCT01961583
Treatments Being Tested
The goal of this clinical research study is to find out if using the tracer...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02193672
Treatments Being Tested
This exploratory study uses \[18F\] Fluciclatide and Positron emission tomo...
Status
Withdrawn
Location
Huntsman Cancer Institute
Start Date
2018-01
Trial ID
NCT01788280
Treatments Being Tested
Background: \- The experimental contrast agent \[18\]F-Fluciclatide is bei...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-04-18
Trial ID
NCT01633255
Treatments Being Tested
The purpose of this study is to assess \[18F\] -fluciclatide as a biomarker...
Status
Completed
Location
Imperial College Healthcare NHS Trust
Start Date
2012-07
Trial ID
NCT01608009
Treatments Being Tested
Angiogenesis and fibrosis lie at the heart of a number of fundamental proce...
Status
Completed
Location
University of Edinburgh
Start Date
2013-04
Trial ID
NCT01813045
Treatments Being Tested
This proof-of-concept study is designed to assess the ability of \[18F\]AH-...
Status
Completed
Location
GE Healthcare Office
Start Date
2007-11
Trial ID
NCT00565721
Treatments Being Tested
Study aimed to assess the reproducibility of PET imaging using AH111585 (18...
Status
Completed
Location
101 Carnegie Center
Start Date
2009-06
Trial ID
NCT00918281
Treatments Being Tested
Background: * Fluciclatide is a small cyclic peptide containing the RGD tr...
Status
Withdrawn
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-07-28
Trial ID
NCT01176500
Treatments Being Tested